1. Group14 Technologies, Inc. (41 from 44 patents)

2. Basf Se Corporation (10 from 5,690 patents)

3. Energ2 Technologies, Inc. (10 from 10 patents)

4. Alkermes Pharma Ireland Limited (6 from 160 patents)

5. Georgia-Pacific Chemicals LLC (5 from 151 patents)

6. Alkermes, Inc. (4 from 75 patents)

7. Alkermes Controlled Therapeutics, Inc. (4 from 46 patents)

8. Amylin Pharmaceuticals, Inc. (3 from 164 patents)

9. Other (2 from 832,912 patents)

10. Alkermes Controlled Therapeutics, Inc. Ii (1 from 36 patents)

11. Marina Biotech, Inc. (1 from 25 patents)

12. Nastech Pharmaceutical Company, Inc. (1 from 21 patents)

13. Retrophin, Inc. (1 from 8 patents)

14. Mdrna, Inc. (1 from 4 patents)

15. Alkernnes Pharma Ireland Limited (1 from 1 patent)

1. 12497479 - Preparation of polymeric resins and carbon materials

2. 12418023 - Composite carbon materials comprising lithium alloying electrochemical modifiers

3. 12173165 - Methods for sol-gel polymerization in absence of solvent and creation of tunable carbon structure from same

4. 12155066 - Decomposition of silicon-containing precursors on porous scaffold materials

5. 12084549 - Preparation of polymeric resins and carbon materials

6. 12064747 - Carbon-based compositions with highly efficient volumetric gas sorption

7. 12057569 - Highly efficient manufacturing of silicon-carbon composite materials comprising ultra low Z

8. 12046744 - Passivated silicon-carbon composite materials

9. 12006400 - Preparation of polymeric resins and carbon materials

10. 11999828 - Preparation of polymeric resins and carbon materials

11. 11942630 - Nano-featured porous silicon materials

12. 11804591 - Highly efficient manufacturing of silicon-carbon composite materials comprising ultra low Z

13. 11732079 - Preparation of polymeric resins and carbon materials

14. 11725074 - Preparation of polymeric resins and carbon materials

15. 11718701 - Preparation of polymeric resins and carbon materials